-

Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)

Court finds non-infringement by Curio Seeker with respect to over-reaching claim by 10x Genomics

PALO ALTO, Calif.--(BUSINESS WIRE)--Curio Bioscience, a leading innovator of high-precision tools for the life sciences industry, today announced that a decision in a court case has been made.

The European Unified Patent Court (UPC) today announced a finding that Curio Seeker does not infringe main claim 1 of EP 2697391 asserted by 10x Genomics (NASDAQ: TXG). The UPC has also ordered Curio Bioscience not to offer any product that would violate claim 14 of the ‘391 patent in France, Germany, and Sweden. Accordingly, Curio Bioscience will comply with the order and expects no impact to its commercial business.

This ruling is restricted to the three countries mentioned and does not affect Curio’s activities elsewhere, nor does it impact other Curio products.

The decision arises from 10x’s request for provisional measures and is open to appeal. The main action remains pending.

Contacts

info@curiobioscience.com

Industry:

Curio Bioscience

Release Versions
English

Contacts

info@curiobioscience.com

More News From Curio Bioscience

Curio Bioscience Launches Trekker Single-Cell Spatial Mapping Kit

PALO ALTO, Calif.--(BUSINESS WIRE)--Curio Bioscience today announced the worldwide availability of Curio Trekker, a new single-cell spatial mapping kit that converts single-cell genomics measurements into tissue-specific spatial data. More than 80 early access customers have already validated this powerful new tool to advance discovery research in cancer biology, neuroscience, developmental sciences and beyond. Making spatial omics more accessible, Curio Trekker delivers true single-cell spatia...

Curio Bioscience Announces Early Access to the World’s First Product to Transform Single-Cell Sequencing Data into Spatial Context

PALO ALTO, Calif.--(BUSINESS WIRE)--Curio Bioscience today announced the commercialization of the world’s first technology that spatially contextualizes single-cell sequencing data, leveraging a breakthrough invention called Slide-tags developed by the Broad Institute of MIT and Harvard and published in Nature this past December. The first stage of Curio’s commercialization of this new product, called Curio Trekker, is an early access program that already includes world-class research organizat...

Curio Bioscience Responds to Lawsuit

PALO ALTO, Calif.--(BUSINESS WIRE)--Curio Bioscience is a leading innovator of high-precision tools for the life sciences industry. Our Curio Seeker product enables whole transcriptome, spatial mapping of fresh frozen tissue at industry-leading resolution and represents the next stage of innovation from our team's inventions of the microarray, stochastic barcoding (unique molecular identifiers), and single cell and spatial tagging and analysis. Our team's inventions of spatial localization of b...
Back to Newsroom